L. R. Bridges

Learn More
Assessment of β-amyloid (Aβ) plaque load in Alzheimer's disease by MRI would provide an important biomarker to monitor disease progression or treatment response. Alterations in tissue structure caused by the presence of Aβ may cause localised changes that can be detected by quantitative T₁ and T₂ relaxation time measurements averaged over larger areas of(More)
  • 1